US Stock MarketDetailed Quotes

TENX Tenax Therapeutics

Watchlist

3.4500
-0.0800-2.27%

Close Jun 7 16:00 ET

3.4500
0.00000.00%

Post 17:24 ET

6.76MMarket Cap-156P/E (TTM)

Tenax Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-199.48%-5.17M

48.16%-5.9M

30.45%-1.17M

37.52%-2.08M

73.10%-922.97K

41.28%-1.72M

-4.90%-11.39M

39.00%-1.69M

-10.24%-3.33M

-85.96%-3.43M

Net income from continuing operations

-170.04%-3.8M

30.21%-7.71M

-26.55%-3.23M

32.39%-1.97M

61.33%-1.11M

48.31%-1.41M

65.98%-11.05M

20.61%-2.55M

23.22%-2.92M

-66.63%-2.86M

Operating gains losses

68.94%118.79K

-47.03%191.98K

-55.26%37.01K

-57.25%37.01K

-56.71%47.64K

-15.35%70.31K

-31.17%362.41K

-61.80%82.73K

-76.80%86.59K

171.04%110.03K

Depreciation and amortization

--0

-93.32%7.57K

-83.88%4.71K

-96.60%969

-96.43%1K

-96.76%895

3.99%113.33K

8.84%29.2K

8.55%28.51K

9.14%28.01K

Other non cash items

79.23%7.96K

439.43%23.97K

--2.82K

2,116.40%8.25K

470.28%8.46K

71.74%4.44K

-99.98%4.44K

--0

--372

341.67%1.48K

Change In working capital

-279.29%-1.49M

292.92%1.58M

168.22%2.01M

70.67%-155.4K

117.79%126.27K

-19.54%-393.76K

-34.55%-820.86K

276.51%748.09K

-241.26%-529.84K

-43,175.00%-709.71K

-Change in receivables

-107.79%-18.29K

14.26%-305.69K

-359.37%-648.53K

-158.75%-96.82K

171.41%204.85K

148.46%234.8K

-1,484.53%-356.52K

101.52%250.04K

36.52%164.8K

-310.81%-286.86K

-Change in payables and accrued expense

-134.69%-1.48M

647.71%1.89M

401.71%2.66M

91.18%-58.59K

80.04%-78.58K

-442.26%-628.57K

36.66%-344.95K

430.68%529.21K

-338.04%-664.1K

-172.59%-393.71K

-Change in other current liabilities

----

--0

----

-177.66%-119.39K

-24.08%-31.15K

-24.07%-30.54K

-533.65%-29.14K

Cash from discontinued investing activities

Operating cash flow

-199.48%-5.17M

48.16%-5.9M

30.45%-1.17M

37.52%-2.08M

73.10%-922.97K

41.28%-1.72M

-4.90%-11.39M

39.00%-1.69M

-10.24%-3.33M

-85.96%-3.43M

Investing cash flow

Cash flow from continuing investing activities

222.38%2.84K

1.6K

119.63%1.24K

-100.51%-2.32K

335.57%4K

Net PPE purchase and sale

--0

222.38%2.84K

--0

--1.6K

119.63%1.24K

55.77%-2.32K

335.57%4K

--0

Cash from discontinued investing activities

Investing cash flow

--0

222.38%2.84K

--0

--1.6K

119.63%1.24K

-100.51%-2.32K

335.57%4K

--0

Financing cash flow

Cash flow from continuing financing activities

-43.47%7.92M

71.10%13.57M

-8,556.91%-174.47K

-86.43%-171.28K

-101.28%-99.91K

6,026.36%14.01M

-18.55%7.93M

2.06K

-101.00%-91.88K

7.79M

Net issuance payments of debt

20.53%-87.73K

---624.3K

---174.47K

-86.43%-171.28K

-22.84%-168.16K

-148.26%-110.4K

--0

---91.88K

---136.89K

Net common stock issuance

-53.05%6.52M

----

--0

-96.26%296.91K

--13.9M

----

--0

--7.93M

Proceeds from stock option exercised by employees

257.32%1.83M

78.97%14.19M

----

--511.31K

-18.55%7.93M

----

Net other financing activities

-20.52%-340.64K

----

---282.65K

----

Cash from discontinued financing activities

Financing cash flow

-43.47%7.92M

71.10%13.57M

-8,556.91%-174.47K

-86.43%-171.28K

-101.28%-99.91K

6,026.36%14.01M

-18.55%7.93M

--2.06K

-101.00%-91.88K

--7.79M

Net cash flow

Beginning cash position

361.09%9.79M

-61.97%2.12M

192.69%11.14M

85.27%13.39M

402.49%14.41M

-61.97%2.12M

-10.66%5.58M

-54.44%3.81M

332.52%7.23M

-18.89%2.87M

Current changes in cash

-77.57%2.76M

321.62%7.67M

19.83%-1.35M

34.19%-2.25M

-123.42%-1.02M

552.67%12.29M

-419.31%-3.46M

39.26%-1.68M

-151.22%-3.42M

333.76%4.36M

End cash Position

-12.94%12.55M

361.09%9.79M

192.69%11.14M

85.27%13.39M

402.49%14.41M

-61.97%2.12M

-54.44%3.81M

332.52%7.23M

Free cash flow

-199.48%-5.17M

48.17%-5.9M

30.29%-1.17M

37.52%-2.08M

73.10%-922.97K

41.41%-1.72M

-4.87%-11.39M

39.18%-1.68M

-10.18%-3.33M

-85.77%-3.43M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-199.48%-5.17M	48.16%-5.9M	30.45%-1.17M	37.52%-2.08M	73.10%-922.97K	41.28%-1.72M	-4.90%-11.39M	39.00%-1.69M	-10.24%-3.33M	-85.96%-3.43M
Net income from continuing operations	-170.04%-3.8M	30.21%-7.71M	-26.55%-3.23M	32.39%-1.97M	61.33%-1.11M	48.31%-1.41M	65.98%-11.05M	20.61%-2.55M	23.22%-2.92M	-66.63%-2.86M
Operating gains losses	68.94%118.79K	-47.03%191.98K	-55.26%37.01K	-57.25%37.01K	-56.71%47.64K	-15.35%70.31K	-31.17%362.41K	-61.80%82.73K	-76.80%86.59K	171.04%110.03K
Depreciation and amortization	--0	-93.32%7.57K	-83.88%4.71K	-96.60%969	-96.43%1K	-96.76%895	3.99%113.33K	8.84%29.2K	8.55%28.51K	9.14%28.01K
Other non cash items	79.23%7.96K	439.43%23.97K	--2.82K	2,116.40%8.25K	470.28%8.46K	71.74%4.44K	-99.98%4.44K	--0	--372	341.67%1.48K
Change In working capital	-279.29%-1.49M	292.92%1.58M	168.22%2.01M	70.67%-155.4K	117.79%126.27K	-19.54%-393.76K	-34.55%-820.86K	276.51%748.09K	-241.26%-529.84K	-43,175.00%-709.71K
-Change in receivables	-107.79%-18.29K	14.26%-305.69K	-359.37%-648.53K	-158.75%-96.82K	171.41%204.85K	148.46%234.8K	-1,484.53%-356.52K	101.52%250.04K	36.52%164.8K	-310.81%-286.86K
-Change in payables and accrued expense	-134.69%-1.48M	647.71%1.89M	401.71%2.66M	91.18%-58.59K	80.04%-78.58K	-442.26%-628.57K	36.66%-344.95K	430.68%529.21K	-338.04%-664.1K	-172.59%-393.71K
-Change in other current liabilities	----	--0	--0	--0	----	----	-177.66%-119.39K	-24.08%-31.15K	-24.07%-30.54K	-533.65%-29.14K
Cash from discontinued investing activities
Operating cash flow	-199.48%-5.17M	48.16%-5.9M	30.45%-1.17M	37.52%-2.08M	73.10%-922.97K	41.28%-1.72M	-4.90%-11.39M	39.00%-1.69M	-10.24%-3.33M	-85.96%-3.43M
Investing cash flow
Cash flow from continuing investing activities	0	222.38%2.84K	0	0	1.6K	119.63%1.24K	-100.51%-2.32K	335.57%4K	0	0
Net PPE purchase and sale	--0	222.38%2.84K	--0	--0	--1.6K	119.63%1.24K	55.77%-2.32K	335.57%4K	--0	--0
Cash from discontinued investing activities
Investing cash flow	--0	222.38%2.84K	--0	--0	--1.6K	119.63%1.24K	-100.51%-2.32K	335.57%4K	--0	--0
Financing cash flow
Cash flow from continuing financing activities	-43.47%7.92M	71.10%13.57M	-8,556.91%-174.47K	-86.43%-171.28K	-101.28%-99.91K	6,026.36%14.01M	-18.55%7.93M	2.06K	-101.00%-91.88K	7.79M
Net issuance payments of debt	20.53%-87.73K	---624.3K	---174.47K	-86.43%-171.28K	-22.84%-168.16K	-148.26%-110.4K	--0	--0	---91.88K	---136.89K
Net common stock issuance	-53.05%6.52M	----	----	--0	-96.26%296.91K	--13.9M	----	----	--0	--7.93M
Proceeds from stock option exercised by employees	257.32%1.83M	78.97%14.19M	----	----	----	--511.31K	-18.55%7.93M	----	----	----
Net other financing activities	-20.52%-340.64K	----	----	----	----	---282.65K	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-43.47%7.92M	71.10%13.57M	-8,556.91%-174.47K	-86.43%-171.28K	-101.28%-99.91K	6,026.36%14.01M	-18.55%7.93M	--2.06K	-101.00%-91.88K	--7.79M
Net cash flow
Beginning cash position	361.09%9.79M	-61.97%2.12M	192.69%11.14M	85.27%13.39M	402.49%14.41M	-61.97%2.12M	-10.66%5.58M	-54.44%3.81M	332.52%7.23M	-18.89%2.87M
Current changes in cash	-77.57%2.76M	321.62%7.67M	19.83%-1.35M	34.19%-2.25M	-123.42%-1.02M	552.67%12.29M	-419.31%-3.46M	39.26%-1.68M	-151.22%-3.42M	333.76%4.36M
End cash Position	-12.94%12.55M	361.09%9.79M	361.09%9.79M	192.69%11.14M	85.27%13.39M	402.49%14.41M	-61.97%2.12M	-61.97%2.12M	-54.44%3.81M	332.52%7.23M
Free cash flow	-199.48%-5.17M	48.17%-5.9M	30.29%-1.17M	37.52%-2.08M	73.10%-922.97K	41.41%-1.72M	-4.87%-11.39M	39.18%-1.68M	-10.18%-3.33M	-85.77%-3.43M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall